Cours en clôture
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
- USD | -.--% |
|
-.--% | -.--% |
Métier
Nombre d'employés: 244
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 26 | 100,0 % | 17 | 100,0 % | -32,42% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 26 | 100,0 % | 17 | 100,0 % | -32,42% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Bobak Azamian
CEO | Chief Executive Officer | 46 | 01/01/17 |
Jeffrey Farrow
DFI | Director of Finance/CFO | 62 | 24/04/23 |
Sesha Neervannan
COO | Chief Operating Officer | 56 | 16/07/20 |
David Nakasone
IRC | Investor Relations Contact | - | - |
Mark Luz
PRN | Corporate Officer/Principal | - | - |
Scott Youmans
SAM | Sales & Marketing | 53 | 01/03/22 |
Bryan Wahl
LAW | General Counsel | 46 | 19/01/21 |
Maáza Martin
SAM | Sales & Marketing | - | - |
Dianne Whitfield
HRO | Human Resources Officer | 47 | 07/01/21 |
Aziz Mottiwala
PRN | Corporate Officer/Principal | 46 | 01/07/20 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Bill Link
BRD | Director/Board Member | 78 | 01/01/17 |
Wendy Yarno
BRD | Director/Board Member | 68 | 19/11/20 |
Director/Board Member | 69 | 01/12/19 | |
Rosemary Crane
BRD | Director/Board Member | 64 | 11/08/21 |
Bobak Azamian
CEO | Chief Executive Officer | 46 | 01/01/17 |
Andrew Goldberg
BRD | Director/Board Member | 42 | 01/08/20 |
Scott Morrison
BRD | Director/Board Member | 66 | 06/10/22 |
Director/Board Member | 45 | 04/01/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 37 781 693 | 33 214 163 ( 87,91 %) | 0 | 87,91 % |
Coordonnées société
![Adresse Tarsus Pharmaceuticals, Inc.](https://cdn.zonebourse.com/static/address/124598190.png)
Secteur
![Consensus](/images/consensus_flch.gif)
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+55,32% | 815 Md | |
+44,05% | 641 Md | |
-6,75% | 352 Md | |
+13,56% | 314 Md | |
+10,68% | 303 Md | |
+16,57% | 242 Md | |
+2,04% | 224 Md | |
+13,31% | 218 Md | |
+8,48% | 168 Md |
- Bourse
- Actions
- Action TARS
- Action
- Société Tarsus Pharmaceuticals, Inc.